CASEE COLLINS: Open Payments
NPI 1114619772 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 37 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $980
Food & beverage: $879Education: $101
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 7 | $287 |
| ABBVIE INC. | 18 | $226 |
| Supernus Pharmaceuticals, Inc. | 2 | $144 |
| Teva Pharmaceuticals USA, Inc. | 6 | $139 |
| Axsome Therapeutics, Inc. | 1 | $89 |
| Otsuka America Pharmaceutical, Inc. | 1 | $48 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: SPRAVATO, Qelbree, INVEGA SUSTENNA, VRAYLAR, Auvelity, REXULTI, UZEDY, COBENFY.
Industry payments across OK — which companies pay providers there.
